ZFGN
Zafgen, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA.
Market Cap: 37.1 Million
Primary Exchange: NASDAQ
Website: http://www.zafgen.com
Shares Outstanding: 37.5 Million
Float: 28.5 Million
Dividend: (%)
Beta: 0.45831714152517194
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1439 trading days
From: 2015-03-19 To: 2020-05-28
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|